Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. [PDF]
Sharma S+8 more
europepmc +1 more source
Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]
Zhu F, Wang H, Qiu L.
europepmc +1 more source
Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia. [PDF]
Gómez C+6 more
europepmc +1 more source
Presence of erythroglycan on human K-562 chronic myelogenous leukemia-derived cells.
Salvatore J. Turco+2 more
openalex +1 more source
Assessment of Treatment Outcome in Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors: Insight From a Resource Limited Setting. [PDF]
Awlachew WY+4 more
europepmc +1 more source
Pericardial Effusion Secondary to Nilotinib in an Elderly Patient With Chronic Myelogenous Leukemia. [PDF]
Arora G+4 more
europepmc +1 more source
Living with chronic myelogenous leukemia in rural communities: Exploring factors related to tyrosine kinase inhibitors adherence with a mixed methods approach. [PDF]
Sheng J+5 more
europepmc +1 more source
Pseudohypoxemia From Leukocyte Larceny in a Patient With Chronic Myelogenous Leukemia. [PDF]
Mirzai S, Andreae M, Puttarajappa C.
europepmc +1 more source
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients [PDF]
H-J Kolb+7 more
openalex +1 more source
Imatinib-Induced Bone Marrow Aplasia in Chronic Myelogenous Leukemia. [PDF]
Dogra R, Dogra V, Shelke AR.
europepmc +1 more source